Squarepoint’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $196K | Buy |
+52,879
| New | +$196K | ﹤0.01% | 2346 |
|
2024
Q4 | – | Sell |
-50,320
| Closed | -$544K | – | 2901 |
|
2024
Q3 | $544K | Sell |
50,320
-59,721
| -54% | -$646K | ﹤0.01% | 1705 |
|
2024
Q2 | $2.31M | Buy |
110,041
+95,422
| +653% | +$2M | ﹤0.01% | 1008 |
|
2024
Q1 | $466K | Buy |
+14,619
| New | +$466K | ﹤0.01% | 1707 |
|
2023
Q4 | – | Sell |
-47,749
| Closed | -$608K | – | 2634 |
|
2023
Q3 | $608K | Buy |
47,749
+33,056
| +225% | +$421K | ﹤0.01% | 1523 |
|
2023
Q2 | $266K | Sell |
14,693
-46,665
| -76% | -$843K | ﹤0.01% | 1925 |
|
2023
Q1 | $1.05M | Sell |
61,358
-768
| -1% | -$13.2K | ﹤0.01% | 1136 |
|
2022
Q4 | $1.38M | Buy |
+62,126
| New | +$1.38M | 0.01% | 946 |
|